Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1984 Aug;74(2):514–524. doi: 10.1172/JCI111449

Role of lipoxygenase products in murine pulmonary granuloma formation.

S L Kunkel, S W Chensue, C Mouton, G I Higashi
PMCID: PMC370504  PMID: 6430962

Abstract

Various arachidonic acid (AA) metabolites are known to regulate immune cell function(s) and dictate the progression of both acute and chronic inflammatory reactions. Using a model of Schistosoma mansoni egg-induced hypersensitivity granulomas, we have delineated the in vivo effects of inhibitors of cyclooxygenase (CO) and lipoxygenase (LO) pathways on granuloma development and granuloma macrophage I-region-associated (Ia) antigen expression. In addition, by high performance liquid chromatography (HPLC) we have profiled the metabolism of AA by macrophages that are isolated from granulomatous foci, and have biochemically characterized the in vitro specificity and activity of selected CO and LO inhibitors. The development of hypersensitivity-type pulmonary granulomas in mice was dramatically suppressed by inhibitors with anti-LO activity (nordihydroguairetic acid (NDGA), nafazatrom, and BW755c) in a dose-dependent manner, while indomethacin, which is primarily CO-selective, had no significant effect. Furthermore, NDGA and nafazatrom profoundly arrested the normal progression of preformed granulomatous lesions. The inhibitors of the LO pathway also suppressed the in vivo kinetics of Ia antigen expression by granuloma macrophages. In contrast, indomethacin augmented Ia-antigen expression. The major AA metabolites that were synthesized by the granuloma macrophages were shown to be leukotriene C4 and mono-hydroxyeicosatetraenoic acids. HPLC analysis of AA metabolites from granuloma macrophages that were treated with the various inhibitors confirmed that indomethacin was most CO-selective and NDGA most LO-selective. Nafazatrom and BW755c inhibited AA metabolism by both pathways. Notably, high concentrations of the compounds (5 X 10(-5) M) tended to suppress all products. Our results suggest that LO products may be important in the generation and maintenance of immune granulomatous inflammatory responses.

Full text

PDF
514

Images in this article

518Image
on p.518

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amsden A. F., Boros D. L. Fc-receptor-bearing macrophages isolated from hypersensitivity and foreign-body granulomas. Delineation of macrophage dynamics, fc receptor density/avidity and specificity. Am J Pathol. 1979 Aug;96(2):457–476. [PMC free article] [PubMed] [Google Scholar]
  2. Bailey J. M., Bryant R. W., Low C. E., Pupillo M. B., Vanderhoek J. Y. Regulation of T-lymphocyte mitogenesis by the leukocyte product 15-hydroxy-eicosatetraenoic acid (15-HETE). Cell Immunol. 1982 Feb;67(1):112–120. doi: 10.1016/0008-8749(82)90203-9. [DOI] [PubMed] [Google Scholar]
  3. Beller D. I., Unanue E. R. IA antigens and antigen-presenting function of thymic macrophages. J Immunol. 1980 Mar;124(3):1433–1440. [PubMed] [Google Scholar]
  4. Chensue S. W., Kunkel S. L., Ward P. A., Higashi G. I. Exogenously administered prostaglandins modulate pulmonary granulomas induced by Schistosoma mansoni eggs. Am J Pathol. 1983 Apr;111(1):78–87. [PMC free article] [PubMed] [Google Scholar]
  5. Chensue S. W., Wellhausen S. R., Boros D. L. Modulation of granulomatous hypersensitivity. II. Participation of Ly 1+ and Ly 2+ T lymphocytes in the suppression of granuloma formation and lymphokine production in Schistosoma mansoni-infected mice. J Immunol. 1981 Jul;127(1):363–367. [PubMed] [Google Scholar]
  6. Crout J. E., Hepburn B., Ritts R. E., Jr Suppression of lymphocyte transformation after aspirin ingestion. N Engl J Med. 1975 Jan 30;292(5):221–223. doi: 10.1056/NEJM197501302920501. [DOI] [PubMed] [Google Scholar]
  7. Darrow T. L., Tomar R. H. Prostaglandin-mediated regulation of the mixed lymphocyte culture and generation of cytotoxic cells. Cell Immunol. 1980 Nov;56(1):172–183. doi: 10.1016/0008-8749(80)90092-1. [DOI] [PubMed] [Google Scholar]
  8. Ford-Hutchinson A. W., Bray M. A., Doig M. V., Shipley M. E., Smith M. J. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980 Jul 17;286(5770):264–265. doi: 10.1038/286264a0. [DOI] [PubMed] [Google Scholar]
  9. Goetz J. M., Sprecher H., Cornwell D. G., Panganamala R. V. Inhibition of prostaglandin biosynthesis by triynoic acids. Prostaglandins. 1976 Aug;12(2):187–192. doi: 10.1016/0090-6980(76)90113-1. [DOI] [PubMed] [Google Scholar]
  10. Goodwin J. S., Webb D. R. Regulation of the immune response by prostaglandins. Clin Immunol Immunopathol. 1980 Jan;15(1):106–122. doi: 10.1016/0090-1229(80)90024-0. [DOI] [PubMed] [Google Scholar]
  11. Gordon D., Bray M. A., Morley J. Control of lymphokine secretion by prostaglandins. Nature. 1976 Jul 29;262(5567):401–402. doi: 10.1038/262401a0. [DOI] [PubMed] [Google Scholar]
  12. Hamberg M., Samuelsson B. On the specificity of the oxygenation of unsaturated fatty acids catalyzed by soybean lipoxidase. J Biol Chem. 1967 Nov 25;242(22):5329–5335. [PubMed] [Google Scholar]
  13. Hammarström S., Hamberg M., Samuelsson B., Duell E. A., Stawiski M., Voorhees J. J. Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis. Proc Natl Acad Sci U S A. 1975 Dec;72(12):5130–5134. doi: 10.1073/pnas.72.12.5130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Higgs G. A., Eakins K. E., Mugridge K. G., Moncada S., Vane J. R. The effects of non-steroid anti-inflammatory drugs on leukocyte migration in carrageenin-induced inflammation. Eur J Pharmacol. 1980 Aug 22;66(1):81–86. doi: 10.1016/0014-2999(80)90297-6. [DOI] [PubMed] [Google Scholar]
  15. Higgs G. A., Flower R. J., Vane J. R. A new approach to anti-inflammatory drugs. Biochem Pharmacol. 1979 Jun 15;28(12):1959–1961. doi: 10.1016/0006-2952(79)90651-8. [DOI] [PubMed] [Google Scholar]
  16. Kelly J. P., Johnson M. C., Parker C. W. Effect of inhibitors of arachidonic acid metabolism on mitogenesis in human lymphocytes: possible role of thromboxanes and products of the lipoxygenase pathway. J Immunol. 1979 Apr;122(4):1563–1571. [PubMed] [Google Scholar]
  17. Kemp J., Louie D., Mattingly J., Bennett J., Higuchi C., Pretell J., Horowitz M., Gershon R. Suppressor cells in vitro: differential effects of indomethacin and related compounds. J Immunopharmacol. 1980;2(4):471–489. doi: 10.3109/08923978009026407. [DOI] [PubMed] [Google Scholar]
  18. Klickstein L. B., Shapleigh C., Goetzl E. J. Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. J Clin Invest. 1980 Nov;66(5):1166–1170. doi: 10.1172/JCI109947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Koren H. S., Anderson S. J., Fischer D. G., Copeland C. S., Jensen P. J. Regulation of human natural killing. I. The role of monocytes, interferon, and prostaglandins. J Immunol. 1981 Nov;127(5):2007–2013. [PubMed] [Google Scholar]
  20. Kunkel S. L., Chensue S. W., Plewa M., Higashi G. I. Macrophage function in the Schistosoma mansoni egg-induced pulmonary granuloma. Role of arachidonic acid metabolites in macrophage Ia antigen expression. Am J Pathol. 1984 Feb;114(2):240–249. [PMC free article] [PubMed] [Google Scholar]
  21. Kunkel S. L., Fantone J. C., Ward P. A., Zurier R. B. Modulation of inflammatory reactions by prostaglandins. Prog Lipid Res. 1981;20:633–640. doi: 10.1016/0163-7827(81)90118-1. [DOI] [PubMed] [Google Scholar]
  22. Kunkel S. L., Thrall R. S., Kunkel R. G., McCormick J. R., Ward P. A., Zurier R. B. Suppression of immune complex vasculitis in rats by prostaglandin. J Clin Invest. 1979 Nov;64(5):1525–1529. doi: 10.1172/JCI109611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Leung K. H., Ehrke M. J., Mihich E. Modulation of the development of cell-mediated immunity: possible role of the products of the cyclo-oxygenase and the lipoxygenase pathways of arachidonic acid metabolism. Int J Immunopharmacol. 1982;4(3):195–204. doi: 10.1016/0192-0561(82)90049-2. [DOI] [PubMed] [Google Scholar]
  24. Leung K. H., Mihich E. Effects of prostaglandins on the development of cell-mediated immunity in culture and on the cytolytic activity of in vivo-generated effector cells. Int J Immunopharmacol. 1982;4(3):205–217. doi: 10.1016/0192-0561(82)90050-9. [DOI] [PubMed] [Google Scholar]
  25. Mertin J., Stackpoole A. Prostaglandin precursors and the cell-mediated immune response. Cell Immunol. 1981 Aug;62(2):293–300. doi: 10.1016/0008-8749(81)90329-4. [DOI] [PubMed] [Google Scholar]
  26. Moore D. L., Grove D. I., Warren K. S. The Schistosoma mansoni egg granuloma: quantitation of cell populations. J Pathol. 1977 Jan;121(1):41–50. doi: 10.1002/path.1711210107. [DOI] [PubMed] [Google Scholar]
  27. Murphy R. C., Hammarström S., Samuelsson B. Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4275–4279. doi: 10.1073/pnas.76.9.4275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Needleman P., Bryan B., Wyche A., Bronson S. D., Eakins K., Ferrendelli J. A., Minkes M. Thromboxane synthetase inhibitors as pharmacological tools: differential biochemical and biological effects on platelet suspensions. Prostaglandins. 1977 Nov;14(5):897–907. doi: 10.1016/0090-6980(77)90306-9. [DOI] [PubMed] [Google Scholar]
  29. O'Flaherty J. T., Thomas M. J., Lees C. J., McCall C. E. Neutrophil-aggregating activity of monohydroxyeicosatetraenoic acids. Am J Pathol. 1981 Jul;104(1):55–62. [PMC free article] [PubMed] [Google Scholar]
  30. Ohuchi K., Sato H., Tsurufuji S. The content of prostaglandin E and prostaglandin F2alpha in the exudate of carrageenin granuloma of rats. Biochim Biophys Acta. 1976 Mar 26;424(3):439–448. doi: 10.1016/0005-2760(76)90033-3. [DOI] [PubMed] [Google Scholar]
  31. Orning L., Hammarström S. Inhibition of leukotriene C and leukotriene D biosynthesis. J Biol Chem. 1980 Sep 10;255(17):8023–8026. [PubMed] [Google Scholar]
  32. Ozato K., Sachs D. H. Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression. J Immunol. 1981 Jan;126(1):317–321. [PubMed] [Google Scholar]
  33. Panayi G. S., Rix A. The effect of phenylbutazone, indomethacin and ibuprofen of lymphocyte stimulation by phytohaemagglutinin in vitro. Rheumatol Rehabil. 1974 Nov;13(4):179–183. doi: 10.1093/rheumatology/13.4.179. [DOI] [PubMed] [Google Scholar]
  34. Piguet P. F., Irle C., Vassalli P. Immunosuppressor cells from newborn mouse spleen are macrophages differentiating in vitro from monoblastic precursors. Eur J Immunol. 1981 Jan;11(1):56–61. doi: 10.1002/eji.1830110112. [DOI] [PubMed] [Google Scholar]
  35. Rand T. H., Turk J., Maas R. L., Colley D. G. Arachidonic acid metabolism of the murine eosinophil. II. Involvement of the lipoxygenase pathway in the response to the lymphokine eosinophil stimulation promoter. J Immunol. 1982 Sep;129(3):1239–1244. [PubMed] [Google Scholar]
  36. Rouzer C. A., Scott W. A., Hamill A. L., Liu F. T., Katz D. H., Cohn Z. A. Secretion of leukotriene C and other arachidonic acid metabolites by macrophages challenged with immunoglobulin E immune complexes. J Exp Med. 1982 Oct 1;156(4):1077–1086. doi: 10.1084/jem.156.4.1077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Scott W. A., Pawlowski N. A., Andreach M., Cohn Z. A. Resting macrophages produce distinct metabolites from exogenous arachidonic acid. J Exp Med. 1982 Feb 1;155(2):535–547. doi: 10.1084/jem.155.2.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Smolen J. E., Weissmann G. Effects of indomethacin, 5,8,11,14-eicosatetraynoic acid, and p-bromophenacyl bromide on lysosomal enzyme release and superoxide anion generation by human polymorphonuclear leukocytes. Biochem Pharmacol. 1980 Feb 15;29(4):533–538. doi: 10.1016/0006-2952(80)90373-1. [DOI] [PubMed] [Google Scholar]
  39. Snyder D. S., Beller D. I., Unanue E. R. Prostaglandins modulate macrophage Ia expression. Nature. 1982 Sep 9;299(5879):163–165. doi: 10.1038/299163a0. [DOI] [PubMed] [Google Scholar]
  40. Snyder D. S., Lu C. Y., Unanue E. R. Control of macrophage Ia expression in neonatal mice--role of a splenic suppressor cell. J Immunol. 1982 Mar;128(3):1458–1465. [PubMed] [Google Scholar]
  41. Stadecker M. J., Wyler D. J., Wright J. A. Ia antigen expression and antigen-presenting function by macrophages isolated from hypersensitivity granulomas. J Immunol. 1982 Jun;128(6):2739–2744. [PubMed] [Google Scholar]
  42. Steeg P. S., Johnson H. M., Oppenheim J. J. Regulation of murine macrophage Ia antigen expression by an immune interferon-like lymphokine: inhibitory effect of endotoxin. J Immunol. 1982 Dec;129(6):2402–2406. [PubMed] [Google Scholar]
  43. Unanue E. R. The regulatory role of macrophages in antigenic stimulation. Part Two: symbiotic relationship between lymphocytes and macrophages. Adv Immunol. 1981;31:1–136. doi: 10.1016/s0065-2776(08)60919-0. [DOI] [PubMed] [Google Scholar]
  44. VanRollins M., Ho S. H., Greenwald J. E., Alexander M., Dorman N. J., Wong L. K., Horrocks L. A. Complete separation by high performance liquid chromatography of metabolites of arachidonic acid from incubation with human and rabbit platelets. Prostaglandins. 1980 Sep;20(3):571–577. doi: 10.1016/0090-6980(80)90044-1. [DOI] [PubMed] [Google Scholar]
  45. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]
  46. Williams R. O., Loeb L. A. Zinc requirement for DNA replication in stimulated human lymphocytes. J Cell Biol. 1973 Sep;58(3):594–601. doi: 10.1083/jcb.58.3.594. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES